Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice

K G Lamping1, D W Nuno, D A Chappell

  • 1Department of Internal Medicine, The Cardiovascular Center, and Department of Veterans Affairs Medical Center, Iowa City, Iowa 52242, USA. kathryn-lamping@uiowa.edu

Related Concept Videos